消息

Carreiro's appointment comes as Digimarc is positioned to capture a significant market opportunity driven by the rapid advancement of AI. The Company's core capabilities in authentication, provenance, and verification deliver trust in every interaction, spanning both the physical and digital worlds.

全文

Digimarc Corporation (NASDAQ: DMRC) has announced the appointment of Paul Carreiro as Chief Executive Officer, effective July 6, 2026. Carreiro brings over 25 years of experience scaling global enterprise software platforms and commercializing advanced technologies worldwide. He joins Digimarc from Elemica, where he propelled the company into the e...

全文

ABM declared a cash dividend of $0.29 per share, payable August 3 , 2026. Interest expense is now forecast at approximately $110 million due to higher rates. In pre‑market trading, shares rose 2.76 % to $40.99 following the Q2 release. Analysts project 3.2 % revenue growth over the next 12 months, a slight deceleration from the past two years, but...

全文

ABM Industries reported Q1 CY2026 revenue of $2.29 billion, an 8.4 % year‑over‑year increase that exceeded analyst estimates by 3.1 %. Adjusted earnings per share were $0.90, 2.4 % above consensus, yet still fell short of the $0.92 estimate, marking the fourth consecutive quarter of EPS misses. Operating margin stayed at 3.8 %, while the adjusted m...

全文

Guardian Pharmacy's strong earnings surprise record is a key driver of its outperformance, having beaten the Zacks Consensus Estimate in each of the last four quarters. The company is expected to post earnings of $1.26 per share on $1.41 in revenues for the current fiscal year, and $1.37 per share on $1.53 in revenues for the next fiscal year.

全文

Shares of Guardian Pharmacy Services (GRDN) have been rising, with the stock up 12.2% over the past month and hitting a new 52‑week high of $41.79 in the previous session. The company has gained 34.5% since the start of the year compared to the -4.4% move for the Zacks Medical sector and the -9.3% return for the Zacks Medical‑Drugs industry.

全文

The stock price is trading 2.6% below the analyst target of €42.84 and 24.6% below Simply Wall St's estimate of fair value. The recent short-term momentum shows a slight increase in share price over the last 30 days. As part of its "RC Forward" plan, Rémy Cointreau will review its portfolio to determine which brands still fit long-term priorities a...

全文

The plan puts ENXTPA:RCO in the middle of ongoing consolidation in spirits, influencing how peers respond. Investors will focus on execution milestones and any announced transactions over the coming periods. The company's current P/E ratio is below the sector average, indicating potential undervaluation. However, profit margins are lower than last...

全文

Rémy Cointreau's "RC Forward" transformation plan aims to reevaluate its entire drinks portfolio for possible disposals and acquisitions, signaling renewed M&A ambitions at a time of sector consolidation in spirits. This strategic review could lead to asset sales, brand swaps or targeted acquisitions, depending on management's assessment of growth...

全文

The fair value estimate for Weir Group (WEIR.L) has been revised downward to £32.46 per share from £33.55. This adjustment reflects analysts' reevaluation of growth expectations and execution risks, with net profit margin remaining largely unchanged at 13.08%. Analysts have also made adjustments to their price targets, with Citi retaining a Buy rat...

全文